North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

Pemmaraju, Naveen; M. Kantarjian, Hagop; Sweet, Kendra; S. Wang, Eunice; Senapati, Jayastu; R. Wilson, Nathaniel; Konopleva, Marina; E. Frankel, Arthur; Gupta, Vikas; A. Mesa, Ruben; L. Ulrickson, Matthew; J. Gorak, Edward; Bhatia, Sumeet; Budak-Alpdoǧan, Tülin; R. Mason, James; Teresa García‐Romero, María; López‐Santiago, Norma; Cesarman‐Maus, Gabriela; Vachhani, Pankit; Lee, Sangmin; Raj Bhatt, Vijaya; Blum, William; B. Walter, Roland; L. Bixby, Dale; Gojo, Ivana; Duvic, Madeleine; K. Rampal, Raajit; de Lima, Marcos; M. Foran, James; T. Fathi, Amir; C. Hall, Aric; A. Jacoby, Meagan; E. Lancet, Jeffrey; N. Mannis, Gabriel; S. Stein, Anthony; S. Mims, Alice; A. Rizzieri, David; L. Olin, Rebecca; E. Perl, Alexander; J. Schiller, Gary; J. Shami, Paul; M. Stone, Richard; A. Strickland, Stephen; J. Wieduwilt, Matthew; Daver, Naval; Ravandi, Farhad; Vasu, Sumithira; L. Guzmán, Mónica; J. Roboz, Gail; D. Khoury, Joseph; H. Qazilbash, Muzaffar; P. Aung, Phyu; Cuglievan, Branko; F. Madanat, Yazan; A. Kharfan‐Dabaja, Mohamed; Pawłowska, Anna; Taylor, Justin; S. Tallman, Martin; Dhakal, Prajwal; A. Lane, Andrew

doi:10.1182/blood.2022017865

Public

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

Published in Blood • Nov 18, 2022

Authors:

Naveen Pemmaraju

Hagop M. Kantarjian

Kendra Sweet

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with historically poor outcomes and no worldwide consensus treatment approach. Unique among most hematologic malignancies for its frequent cutaneous involvement, BPDCN can also invade other extramedullary compartme...

Subject

Medicine

Interleukin-3 receptor

Hematologic malignancy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!